Complete fractional flow reserve-guided revascularization in patients with STEMI and multivessel disease did not affect final infarct size, LV function, or remodeling compared with culprit-only percutaneous coronary intervention.
A recently published report describes two patient cases involving clopidogrel-induced acute migratory polyarthritis and highlights the importance of timely intervention for this condition.
Most patients with STEMI are treated in the ICU.
The incident rate of developing an ICU-associated complication was linked to reperfusion delays in stable patients with STEMI.
Genus Lifesciences has announced the re-introduction of Yosprala delayed-release tablets to the US market.
There has been a rise in the prevalence of multiple organ failure in patients with cardiogenic shock complicating acute myocardial infarction.
Seniors have increased incidence of cardiac arrest, in-hospital mortality.
TherOx has received premarket approval from the FDA for SuperSaturated Oxygen Therapy for use in patients who suffer left anterior descending STEMI.
Depression is common in patients with chronic total occlusion, and has been linked to more severe baseline angina.
Short-term mortality and readmission rates after acute MI have improved during the last 20 years among Medicare beneficiaries.